ReviewZentralblatt fur Gynakologie1988
[Exogenous harmful substances in pregnancy and their effects on the embryo and fetus].
Review in Zentralblatt fur Gynakologie, 1988. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
- Comment on
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
When using drugs during pregnancy the advantages and risks of a therapy have to be considered carefully. In order to assess the risk of possible teratogenic effects under the influence of external harmful substances the following factors have to be taken into account: the type of the drug administered, kind, dose and duration of the medication, impaired metabolism of drugs owing to diseases of te mother, placenta transfer, time of the exposition during pregnancy, genetic disposition. As in other cases in pharmacology and toxicology there are clear relations of dose and effect as a result of an exposition. High doses, administered for a short time, are extremely dangerous as they may affect the fetus. A deleterious effect on the fetus in the first trimester results in abortions and malformations, in the second and third trimester in general retardations of the fetal development, postnatal impairments of the functional development, increasing perinatal mortality, premature deliveries, stillbirths, transplacental carcinogesis. A long-term exposition or the administration of high doses of different substances at the end of pregnancy may produce syndromes which may possibly endanger the newborn. Following drugs are among these pharmacons: Benzodiazepines, Neuroleptics, tricyclic antidepressants, Lithium, Beta-receptor-blocking agents, Beta-sympathomimetics using as tocolytics, Captopril. Withdrawal syndromes of the newborns have been described after a long-term therapy with certain drugs or due to drug addiction of the mother. In every pregnancy there is a certain risk of giving birth to an abnormal child. Malformations observed at birth or immediately afterwards happen according to the definition with a frequency of 2 to 4% (FRG), according to sources from other countries with a frequency of 2.5 to 6.5%. If you add anomalies diagnosed within first year of life a deformity rate of 10% can be worked out, approximately 4 to 5% of which can be traced back to the exposition to drugs and environmental chemicals. A teratogenic influence would always have to work together with other factors to cause a faulty development of the fetus.
Indexed as
Identifiers
3066064W171570686What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.